Maybe you should actually read the presentation. It's linked to the front page of Insmed's website. You will be surprised to see 2 brand new charts that show Arikace "beating" Tobi head-to-head at the end of 3 cycles.
Thanks, Will, for not PR'ing this so we could read it and make decisions without a sell-on-the-news event. I do expect a PR, though!
Not "gloating" I hope Arikace gets an approval. Novices like you can not and should not try an analyze something they neither have the full story nor the background.Had there been earth shattering game changing news - the analysts here ( shorts supporters btw) would have been spilling it other news media outlets.
gloating YTD= 110%
Well the stock did what I thought it would,I was hoping to be wrong and for shorts to starve on this round but we flew up to fast and hard for them not to.Just hope it trades sideways until we get some more upgrades to take us up and over that 16.50.My advice is buy in pieces on the dip,you`ll make money soon enough.
I wouldn't call it earth-shattering or game-changing, more like a deeper revelation into the efficacy and real-world capability of Arikace vs. its competition in the CF space. I think the analysts are already quite high on Insmed, but I think we get an initiation or two in the near term. Finally, don't you wish you had gambled long on PRKR two days ago? I seriously thought about it, but seemed quite the risky venture!